Zimmer Biomet Holdings (ZBH) Change in Receivables (2009 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Change in Receivables came in at -$14.5 million in Q1 2026, down 177.13% year-on-year from $18.8 million in Q1 2025, and down 112.98% quarter-over-quarter from $111.7 million in Q4 2025.
Zimmer Biomet Holdings (ZBH) Change in Receivables (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Change in Receivables history runs 18 years deep, the most recent figure standing at -$14.5 million for Q1 2026.
- On a quarterly basis, Change in Receivables fell 177.13% year-over-year to -$14.5 million in Q1 2026; TTM through Mar 2026 was $94.0 million, a 9.56% increase from a year earlier, with the FY2025 full-year figure at $127.3 million, up 41.92% from the prior year.
- Change in Receivables retreated to -$14.5 million in Q1 2026 per ZBH's latest filing, from $111.7 million in the prior quarter.
- Across five years, Change in Receivables topped out at $111.7 million in Q4 2025 and bottomed at -$14.5 million in Q1 2026.
- The 5-year median for Change in Receivables is $18.8 million (2025), against an average of $25.8 million.
- Across the five-year window, Change in Receivables jumped 1157.69% in 2022 and slumped 2183.33% in 2024, its largest moves.
- Year by year, Change in Receivables stood at $70.2 million in 2022, then fell by 3.99% to $67.4 million in 2023, then slipped by 26.41% to $49.6 million in 2024, then jumped by 125.2% to $111.7 million in 2025, then tumbled by 112.98% to -$14.5 million in 2026.
- Per Business Quant, the three latest ZBH Change in Receivables figures stand at -$14.5 million (Q1 2026), $111.7 million (Q4 2025), and -$3.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn | -14.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.50 Mn |
| Mar 31, 2026 | -14.50 Mn |
| Dec 31, 2025 | 111.70 Mn |
| Dec 31, 2025 | 111.70 Mn |
| Sep 30, 2025 | -3.00 Mn |
| Sep 30, 2025 | -3.00 Mn |
| Jun 30, 2025 | -200,000.00 |
| Jun 30, 2025 | -200,000.00 |
| Mar 31, 2025 | 18.80 Mn |
| Mar 31, 2025 | 18.80 Mn |
| Dec 31, 2024 | 49.60 Mn |
| Dec 31, 2024 | 49.60 Mn |
| Sep 30, 2024 | 29.90 Mn |
| Sep 30, 2024 | 29.90 Mn |
| Jun 30, 2024 | -12.50 Mn |
| Jun 30, 2024 | -12.50 Mn |
| Mar 31, 2024 | 22.70 Mn |
| Mar 31, 2024 | 22.70 Mn |
| Dec 31, 2023 | 67.40 Mn |
| Dec 31, 2023 | 67.40 Mn |